Cell line · CVCL_2760
Papers44
1 to 20 of 44
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Chlorothiophene-Substituted N-Phenylpyrazolines: Synthesis, Anticancer Evaluation, and Computational Insight into COX-2 Inhibition. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Preventive Effect of Butyrate in Colon Cancer Cell Metabolism. | Int J Mol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Downregulation of cGAS/STING expression in tumor cells by cancer-associated fibroblasts in colorectal cancer. | Sci Rep | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Antitumor effects of immunotherapy combined with BRAF and MEK inhibitors in BRAF V600E metastatic colorectal cancer. | Cancer Immunol Immunother | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Bidirectional signals generated by Siglec-7 and its crucial ligand tri-sialylated T to escape of cancer cells from immune surveillance. | iScience | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Reduced chemokine C-C motif ligand 1 expression may negatively regulate colorectal cancer progression at liver metastatic sites. | J Cell Mol Med | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models. | Mol Oncol | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells. | Cell Rep Med | 2024 | Its Methods give the RRID and name the line | PubMed | |
| CBF-Beta Mitigates PI3K-Alpha-Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer. | Mol Cancer Res | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Downregulation of protein kinase C gamma reduces epithelial property and enhances malignant phenotypes in colorectal cancer cells. | iScience | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Functional genetic screen identifies ITPR3/calcium/RELB axis as a driver of colorectal cancer metastatic liver colonization. | Dev Cell | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer. | J Exp Clin Cancer Res | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Ascorbic Acid Chemosensitizes Colorectal Cancer Cells and Synergistically Inhibits Tumor Growth. | Front Physiol | 2018 | Its Methods give the RRID and name the line | PubMed | |
| The Dietary Supplement Chondroitin-4-Sulfate Exhibits Oncogene-Specific Pro-tumor Effects on BRAF V600E Melanoma Cells. | Mol Cell | 2018 | Its Methods give the RRID and name the line | PubMed | |
| Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies. | Mol Cancer | 2017 | Cellosaurus cites it | PubMed | |
| N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression. | Mol Cell Proteomics | 2016 | Cellosaurus cites it | PubMed | |
| TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression. | Genome Med | 2015 | Cellosaurus cites it | PubMed | |
| Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment. | Clin Cancer Res | 2015 | Cellosaurus cites it | PubMed | |
| The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets. | Nat Commun | 2015 | Cellosaurus cites it | PubMed | |
| A comprehensive transcriptional portrait of human cancer cell lines. | Nat Biotechnol | 2015 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_2760/papers